• Home
        •  | 
        • Partners log-in
      • About Cupron
        • News & Events
        • In the media
        • Cupron Management
        • Regulation
        • FAQ
        • Contact
      • Markets
        • Consumer
        • Industrial
        • Medical
        • Military
      • Cupron Technology
        • The Power of Copper
        • The Cupron Difference
        • Safety Testing
        • The Environment
        • Scientific Data
      • Manufacturing
        • Manufacturing Process
        • Different Substrates
    •  News & Events
    • In the media
    • Cupron Management
    • Regulation
    • FAQ
    • Contact
    • Follow Us

    • Home
    •  › 
    • About Cupron
    •  › 
    • News & Events
    •  › 
    • Scientific Publication of Socks help the miners

    Scientific Publication of Socks help the miners

    January 2012

     

    In January 2012 Cupron's help to the Chilean miners got scientific recognition and a study that was done on the miner's condition was published in the prestigious medical journal – Archives of Dermatology published by the American Medical Association. The study examined the effect of the socks on the wellbeing of the trapped miners and details how the socks helped them to fight foot fungus. In most cases the different symptoms significantly improved/resolved within 4 to 7 days. This is another support to the effectiveness of our technology, and a scientific recognition to the humanitarian help we provided to the miners in time of need. Please contact us to get a copy of the article.

     

     

    •  
      • © Copyright Cupron 2008, All rights reserved.
        • Cupron
        •   |  
        • About Cupron
        •   |  
        • Markets
        •   |  
        • The Power of Copper
        •   |  
        • FAQ
        •   |  
        • Cupron Technology
        •   |  
        • Manufacturing

      • Product claims that can be made for products containing Cupron technology vary by country and by product. In particular, all antimicrobial claims in the US
        are strictly regulated by the US EPA, which allows only preservative "treated article" claims, while structure-function/disease-treatment claims in the US need
        to be pre-market approved by the US FDA. Partners and customers should consult Cupron for all questions regarding product claims in particular countries

    •